KNBIF (Kane Biotech) Other Stockholders Equity: $0.01 Mil (As of Mar. 2026)


What is Kane Biotech Other Stockholders Equity?

Kane Biotech KNBIF +5.19% Other Stockholders Equity is $0.01 Mil as of Mar. 2026. The stock has 6 warning signs investors should review.

Kane Biotech's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $0.01 Mil.

Kane Biotech's quarterly Other Stockholders Equity declined from Sep. 2025 ($0.01 Mil) to Dec. 2025 ($0.01 Mil) but then increased from Dec. 2025 ($0.01 Mil) to Mar. 2026 ($0.01 Mil).

Kane Biotech's annual Other Stockholders Equity declined from Dec. 2023 ($0.10 Mil) to Dec. 2024 ($0.05 Mil) and declined from Dec. 2024 ($0.05 Mil) to Dec. 2025 ($0.01 Mil).

Kane Biotech Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Kane Biotech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kane Biotech Other Stockholders Equity Chart

Kane Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.30 0.00 0.10 0.05 0.01

Kane Biotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Kane Biotech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0.01 Mil mean?
Kane Biotech (KNBIF) has a Other Stockholders Equity of $0.01 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Kane Biotech and its competitors.
Is Kane Biotech's Other Stockholders Equity too high?
Kane Biotech's current Other Stockholders Equity is $0.01 Mil.
How does Kane Biotech's Other Stockholders Equity compare to VRTX and REGN?
Kane Biotech's Other Stockholders Equity of $0.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Kane Biotech and its competitors. Kane Biotech's current Other Stockholders Equity is $0.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kane Biotech stock overvalued right now?
Kane Biotech (KNBIF) has a current Other Stockholders Equity of $0.01 Mil. The current Other Stockholders Equity is $0.01 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Kane Biotech (KNBIF), the current Other Stockholders Equity is $0.01 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kane Biotech Business Description

Other Exchanges KNE:Canada
Address 290-100 Innovation Drive, Winnipeg, MB, CAN, R3T 6G2
Kane Biotech Inc is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The company has a portfolio of biotechnologies, intellectual property and products developed by its own biofilm research expertise and acquired from research institutions. The company's operating segments are animal health and human health. It derives maximum revenue from Animal health segment.